BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced its strategic plan to transition from a prescription to a non-prescription business model. The ...
A year after getting FDA clearance for its video game treatment for ADHD, Akili Interactive CEO Eddie Martucci said he’s happy with the early response from doctors and patients. But the company still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback